Although PD-1 blockade is certainly a static method to revive exhausted anti-tumor CD8+ T-cells, on the other side, pre-existing Tregs present in the TME can also become more active and apply pronounced suppression on naive T cells undergoing activation [50]. The gene discussed is PDCD1; the disease is neoplasm.